WA
Waverly Advisors Portfolio holdings
AUM
$9.11B
This Quarter Return
+7.32%
1 Year Return
+14.7%
3 Year Return
+51.09%
5 Year Return
+83.3%
10 Year Return
+138.78%
AUM
$761M
AUM Growth
+$761M
(+9.2%)
Cap. Flow
-$1.72M
Cap. Flow
% of AUM
-0.23%
Top 10 Holdings %
Top 10 Hldgs %
64.89%
Holding
141
New
8
Increased
26
Reduced
78
Closed
1
Top Buys
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
$2.11M |
| 2 |
Boeing
BA
|
$1.82M |
| 3 |
SPDR Portfolio Aggregate Bond ETF
SPAB
|
$1.65M |
| 4 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
$1.41M |
| 5 |
Invesco FTSE RAFI Emerging Markets ETF
PXH
|
$1.3M |
Top Sells
| 1 |
iShares Russell 3000 ETF
IWV
|
$2.66M |
| 2 |
iShares MSCI EAFE Value ETF
EFV
|
$2.18M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
$1.33M |
| 4 |
Vanguard Russell 1000 ETF
VONE
|
$1.3M |
| 5 |
iShares Russell 2000 Value ETF
IWN
|
$1.2M |
Sector Composition
| 1 | Financials | 1.71% |
| 2 | Technology | 1.62% |
| 3 | Industrials | 0.94% |
| 4 | Consumer Staples | 0.64% |
| 5 | Healthcare | 0.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
3M
MMM
$82.8B
| $217K | 0.03% | 1,332 -386 | -22% | -$62.9K |
|
127
Huntington Bancshares
HBAN
$26B
| $216K | 0.03% | 15,444 | – | – |
|
128
Bristol-Myers Squibb
BMY
$96B
| $210K | 0.03% | +3,128 | New | +$210K |
|
129
Applied Materials
AMAT
$128B
| $209K | 0.03% | +3,313 | New | +$209K |
|
130
Vanguard Total International Bond ETF
BNDX
$68.3B
| $209K | 0.03% | 3,636 | – | – |
|
131
AbbVie
ABBV
$372B
| $207K | 0.03% | +2,380 | New | +$207K |
|
132
S&P Global
SPGI
$167B
| $207K | 0.03% | +699 | New | +$207K |
|
133
US Bancorp
USB
$76B
| $206K | 0.03% | 3,767 -126 | -3% | -$6.89K |
|
134
Altria Group
MO
$113B
| $205K | 0.03% | +4,395 | New | +$205K |
|
135
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.6B
| $190K | 0.03% | 19,812 | – | – |
|
|
MCR
136
MFS Charter Income Trust
MCR
$266M
| $94K | 0.01% | 11,020 | – | – |
|
137
SiriusXM
SIRI
$7.96B
| $80K | 0.01% | 11,154 -4,993 | -31% | -$35.8K |
|
138
BioCryst Pharmaceuticals
BCRX
$1.74B
| $67K | 0.01% | 22,429 | – | – |
|
|
RFP
139
DELISTED
Resolute Forest Products Inc.
RFP
| $35K | ﹤0.01% | 10,841 -64 | -0.6% | -$207 |
|
|
CELG
140
DELISTED
Celgene Corp
CELG
| – | – | -2,146 | Closed | -$213K |
|